Bruce G. Allen Investments, LLC Biomarin Pharmaceutical Inc Transaction History
Bruce G. Allen Investments, LLC
- $129 Billion
- Q3 2024
A detailed history of Bruce G. Allen Investments, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Bruce G. Allen Investments, LLC holds 30 shares of BMRN stock, worth $1,952. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30
Previous 39
23.08%
Holding current value
$1,952
Previous $3.21 Million
34.32%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BMRN
# of Institutions
638Shares Held
178MCall Options Held
2.01MPut Options Held
1.28M-
Black Rock Inc. New York, NY22.7MShares$1.48 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.3MShares$1.25 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.9MShares$1.23 Billion0.99% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$905 Million0.59% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.5MShares$683 Million0.16% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.1B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...